On the public citation graph

COVID-19 Vaccine Safety in Cancer Patients: A Single Centre Experience

https://doi.org/10.3390/cancers13143573
0 signed · 86 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2021.5374openalex-snapshot
Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines
inferredcites →https://doi.org/10.1002/1097-0142(19840615)53:12<2619::aid-cncr2820531209>3.0.co;2-dopenalex-snapshot
Effect on immunologic and other indices of adjuvant cytotoxic chemotherapy including melphalan in breast cancer
inferredcites →https://doi.org/10.1016/j.annonc.2020.05.009openalex-snapshot
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic
inferredcites →https://doi.org/10.1016/j.annonc.2021.01.068openalex-snapshot
The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate
inferredcites →https://doi.org/10.1016/j.coi.2017.06.009openalex-snapshot
No pain no gain? Adjuvant effects of alum and monophosphoryl lipid A in pertussis and HPV vaccines
inferredcites →https://doi.org/10.1016/j.ejca.2020.08.011openalex-snapshot
Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies
inferredcites →https://doi.org/10.1016/j.ejca.2021.03.035openalex-snapshot
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
inferredcites →https://doi.org/10.1016/s0140-6736(20)31604-4openalex-snapshot
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
inferredcites →https://doi.org/10.1016/s0140-6736(20)32466-1openalex-snapshot
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
inferredcites →https://doi.org/10.1016/s0140-6736(20)32661-1openalex-snapshot
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
inferredcites →https://doi.org/10.1016/s0140-6736(21)01115-6openalex-snapshot
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
inferredcites →https://doi.org/10.1016/s1470-2045(20)30388-0openalex-snapshot
The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study
inferredcites →https://doi.org/10.1016/s1470-2045(21)00155-8openalex-snapshot
Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors
inferredcites →https://doi.org/10.1016/s1470-2045(21)00213-8openalex-snapshot
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
inferredcites →https://doi.org/10.1016/s1473-3099(21)00224-3openalex-snapshot
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
inferredcites →https://doi.org/10.1038/s41541-019-0132-6openalex-snapshot
The how’s and what’s of vaccine reactogenicity
inferredcites →https://doi.org/10.1056/nejmc2101667openalex-snapshot
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
inferredcites →https://doi.org/10.1056/nejmoa2027906openalex-snapshot
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
inferredcites →https://doi.org/10.1056/nejmoa2034577openalex-snapshot
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
inferredcites →https://doi.org/10.1056/nejmoa2035389openalex-snapshot
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
inferredcites →https://doi.org/10.1056/nejmoa2104840openalex-snapshot
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
inferredcites →https://doi.org/10.1056/nejmoa2104882openalex-snapshot
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
inferredcites →https://doi.org/10.1080/21645515.2015.1062189openalex-snapshot
Practical review of immunizations in adult patients with cancer
inferredcites →https://doi.org/10.1093/jnci/djab012openalex-snapshot
Prevalence of Underlying Medical Conditions Associated With Severe COVID-19 Illness in Adult Cancer Survivors in the United States
inferredcites →https://doi.org/10.1158/2159-8290.cd-20-1817openalex-snapshot
Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited
inferredcites →https://doi.org/10.1186/s12885-020-6667-0openalex-snapshot
Guy’s cancer cohort – real world evidence for cancer pathways
inferredcites →https://doi.org/10.1186/s13045-021-01046-wopenalex-snapshot
COVID-19 vaccines for patients with cancer: benefits likely outweigh risks
inferredcites →https://doi.org/10.1186/s13058-015-0669-xopenalex-snapshot
Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer
inferredcites →https://doi.org/10.1200/go.20.00351openalex-snapshot
Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study
inferredcites →https://doi.org/10.1200/jco.1985.3.5.718openalex-snapshot
Immunogenicity of hepatitis B vaccine in oncology patients receiving chemotherapy.
inferredcites →https://doi.org/10.1200/jco.2002.02.041openalex-snapshot
Randomized Trial of Influenza Vaccine With Granulocyte-Macrophage Colony-Stimulating Factor or Placebo in Cancer Patients
inferredcites →https://doi.org/10.1371/journal.pone.0247461openalex-snapshot
Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis
inferredcites →https://doi.org/10.7326/0003-4819-87-5-552openalex-snapshot
Influenza Immunization of Adult Patients with Malignant Diseases

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3979664openalex-extracted
A Web-Based Survey on Factors for Unvaccination and Adverse Reactions of SARS-CoV-2 Vaccines in Chinese Postoperative Patients With Breast Cancer
inferred← citeshttps://doi.org/10.1002/cam4.5400openalex-snapshot
Perception and safety analysis of COVID‐19 vaccination in cancer patients: A multicenter, real‐world study
inferred← citeshttps://doi.org/10.1016/j.ejca.2022.05.029openalex-snapshot
Booster doses of COVID-19 vaccines for patients with haematological and solid cancer: a systematic review and individual patient data meta-analysis
inferred← citeshttps://doi.org/10.1016/j.gore.2023.101140openalex-snapshot
Surveillance of gynecologic cancer patients post-COVID-19 vaccine: Are CA-125 levels reliable?
inferred← citeshttps://doi.org/10.1016/j.intimp.2022.109046openalex-snapshot
A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies
inferred← citeshttps://doi.org/10.1016/j.lfs.2023.121569openalex-snapshot
Anti-cancer effect of COVID-19 vaccines in mice models
inferred← citeshttps://doi.org/10.1016/j.micpath.2024.106955openalex-snapshot
COVID-19 vaccination anti-cancer impact on the PI3K/AKT signaling pathway in MC4L2 mice models
inferred← citeshttps://doi.org/10.1016/j.puhe.2022.09.001openalex-snapshot
COVID-19 vaccine acceptance and hesitancy among patients with cancer: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.vaccine.2021.12.046openalex-snapshot
Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial
inferred← citeshttps://doi.org/10.1016/j.vaccine.2025.127342openalex-snapshot
COVID-19 vaccine safety studies among special populations: A systematic review and meta-analysis of 120 observational studies and randomized clinical trials
inferred← citeshttps://doi.org/10.1051/nso/2022004openalex-snapshot
Challenges of COVID-19 vaccination in patients with cancer
inferred← citeshttps://doi.org/10.1080/00913847.2023.2186691openalex-snapshot
Reported COVID-19 vaccines side effects among Algerian athletes: a comparison between inactivated virus, adenoviral vector, and mRNA COVID-19 vaccines
inferred← citeshttps://doi.org/10.1080/21645515.2022.2102329openalex-snapshot
COVID-19 vaccination perception and uptake among cancer patients in Guangzhou, China
inferred← citeshttps://doi.org/10.1093/oncolo/oyad067openalex-snapshot
Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort Analysis
inferred← citeshttps://doi.org/10.1101/2022.04.19.22274047openalex-snapshot
COVID-19 outcomes by cancer status, type, treatment, and vaccination
inferred← citeshttps://doi.org/10.1101/2024.06.02.24308345openalex-snapshot
Vaccine beliefs, adverse effects, and quality of life in patients with cancer undergoing routine COVID-19 vaccination
inferred← citeshttps://doi.org/10.1101/2024.12.27.24319417openalex-snapshot
COVID-19 Vaccine Safety Studies among Vulnerable Populations: A Systematic Review and Meta-analysis of 120 Observational Studies and Randomized Clinical Trials
inferred← citeshttps://doi.org/10.1111/ajco.13959openalex-snapshot
Comparison of antibody response to coronavirus disease 2019 vaccination between patients with solid or hematologic cancer patients undergoing chemotherapy
inferred← citeshttps://doi.org/10.1158/1055-9965.epi-22-0607openalex-snapshot
COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination
inferred← citeshttps://doi.org/10.1158/2159-8290.cd-21-1368openalex-snapshot
Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer
inferred← citeshttps://doi.org/10.1159/000542281openalex-snapshot
Immunogenicity and Safety of COVID-19 Vaccines in Patients with Lung Cancer: Results of a Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.11648/j.ijcocr.20220702.13openalex-snapshot
COVID-19 Vaccine Safety in Cancer Patients: A Single Center Experience
inferred← citeshttps://doi.org/10.1177/10781552241285034openalex-snapshot
Local and systemic side effects of COVID-19 vaccine in Tunisian cancer patients: A prospective single center study
inferred← citeshttps://doi.org/10.1177/11795549221123618openalex-snapshot
Changes in Behavior After Vaccination and Opinions Toward Mask Wearing: Thoracic Oncology Patient–Reported Experiences During the COVID-19 Pandemic
inferred← citeshttps://doi.org/10.1177/23743735251360831openalex-snapshot
Impact of COVID-19 Pandemic on the Management of Oncology Patients in Eastern Canada
inferred← citeshttps://doi.org/10.1186/s13045-022-01265-9openalex-snapshot
Safety of two-dose COVID-19 vaccination (BNT162b2 and CoronaVac) in adults with cancer: a territory-wide cohort study
inferred← citeshttps://doi.org/10.1360/nso/20220004openalex-snapshot
Challenges of COVID-19 vaccination in patients with cancer
inferred← citeshttps://doi.org/10.1371/journal.pone.0296669openalex-snapshot
Reported side-effects following Oxford/AstraZeneca COVID-19 vaccine in the north-west province, Iran: A cross-sectional study
inferred← citeshttps://doi.org/10.21037/atm-22-5838openalex-snapshot
Willingness to receive COVID-19 vaccination and adverse effects after vaccination in breast cancer survivors during the COVID-19 pandemic: a cross-sectional retrospective study of a Chinese population
inferred← citeshttps://doi.org/10.21037/gs-22-454openalex-snapshot
A web-based survey of SARS-CoV-2 vaccination and its adverse effects in Chinese postoperative patients with breast cancer: a cross-sectional study
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1202932/v1openalex-snapshot
A web-based survey on factors for unvaccination and adverse reactions of SARS-CoV-2 vaccines in Chinese postoperative patients with breast cancer
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1202932/v3openalex-snapshot
A web-based survey on factors for unvaccination and adverse reactions of SARS-CoV-2 vaccines in Chinese postoperative patients with breast cancer
inferred← citeshttps://doi.org/10.2196/35310openalex-snapshot
COVID-19 Diagnosis and Risk of Death Among Adults With Cancer in Indiana: Retrospective Cohort Study
inferred← citeshttps://doi.org/10.22037/aaem.v10i1.1597openalex-snapshot
Safety and Adverse Events Related to COVID-19 mRNA Vaccines; a Systematic Review.
inferred← citeshttps://doi.org/10.2217/imt-2021-0342openalex-snapshot
Development of Hepatitis Triggered by SARS-CoV-2 Vaccination in Patient with Cancer During Immunotherapy: A Case Report
inferred← citeshttps://doi.org/10.3389/fonc.2022.1014786openalex-snapshot
Cancer patients and COVID-19 vaccination, from safety to protocol adherence: A real-life setting report
inferred← citeshttps://doi.org/10.3389/fonc.2022.1029325openalex-snapshot
COVID-19 vaccination in patients with cancer: Opportunities and challenges
inferred← citeshttps://doi.org/10.3389/fonc.2022.855723openalex-snapshot
mRNA-COVID19 Vaccination Can Be Considered Safe and Tolerable for Frail Patients
inferred← citeshttps://doi.org/10.3389/fonc.2022.951026openalex-snapshot
Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: Results of a prospective observational study
inferred← citeshttps://doi.org/10.3389/fonc.2023.1034466openalex-snapshot
Efficacy and safety of COVID-19 vaccines for patients with spinal tumors receiving denosumab treatment: An initial real−clinical experience study
inferred← citeshttps://doi.org/10.3389/fpubh.2023.1119163openalex-snapshot
COVID-19 vaccination status, side effects, and perceptions among breast cancer survivors: a cross-sectional study in China
inferred← citeshttps://doi.org/10.3390/cancers14225630openalex-snapshot
Cancer Patients and the COVID-19 Vaccines: Considerations and Challenges
inferred← citeshttps://doi.org/10.3390/healthcare11020248openalex-snapshot
Cancer Patients during COVID-19 Pandemic: A Mini-Review
inferred← citeshttps://doi.org/10.3390/vaccines10010012openalex-snapshot
Pfizer-BioNTech COVID-19 Vaccine in Gynecologic Oncology Patients: A Prospective Cohort Study
inferred← citeshttps://doi.org/10.3390/vaccines10060892openalex-snapshot
Safety and Tolerability of COVID-19 Vaccines in Patients with Cancer: A Single Center Retrospective Analysis
inferred← citeshttps://doi.org/10.3390/vaccines10091373openalex-snapshot
COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers
inferred← citeshttps://doi.org/10.3390/vaccines11020356openalex-snapshot
Safety Following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVac
inferred← citeshttps://doi.org/10.3390/vaccines13070715openalex-snapshot
Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Radiation–Oncology Patients: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.36131/cnfioritieditore20220602openalex-snapshot
The Relationship Between Covid-19 Risk Perception and Vaccine Hesitancy in Cancer Patients: The Moderating Role of Externalizing Traits.
inferred← citeshttps://doi.org/10.3889/oamjms.2022.9934openalex-snapshot
Gastrointestinal Cancer and Vaccination Safety during COVID-19 Pandemic
inferred← citeshttps://doi.org/10.46969/ezh.987295openalex-snapshot
Covid-19 Aşısının Kadın Sağlığı Üzerine Olan Etkileri
inferred← citeshttps://doi.org/10.52711/2349-2988.2024.00037openalex-snapshot
Comprehensive review of Respiratory Syncytial Virus (RSV) Vaccination: Progress, Challenges, and Future Direction
inferred← citeshttps://doi.org/10.6084/m9.figshare.19802324openalex-snapshot
Additional file 1 of Safety of two-dose COVID-19 vaccination (BNT162b2 and CoronaVac) in adults with cancer: a territory-wide cohort study
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.